Fundamental Analysis Stories

ODP
  over two months ago at Macroaxis 
By Gabriel Shpitalnik
Office Depot Invested Capital is very stable at the moment as compared to the past year. Office Depot reported last year Invested Capital of 4.07 Billion. As of 3rd of November 2021, Tangible Asset Value is likely to grow to about 6.2 B, while Invested Capital Average is likely to drop about 4.2 B. There are many examples of prices declining after a drastic change in one of the fundamental indicators. In this short article, we will recap a few of Office Depot's essential fundamentals. We will evaluate why recent Office Depot price moves suggest a bounce in December. The entity current odds of distress is under 42 percent. Will insiders continue to be optimistic, or should we expect a sell-off?
KOPN
  over two months ago at Macroaxis 
By Raphi Shpitalnik
Kopin Cp Tangible Asset Value is quite stable at the moment as compared to the past year. The company's current Tangible Asset Value is estimated at 93.67 Million. Working Capital is expected to rise to about 70.1 M this year, although the value of Net Income Per Employee will most likely fall to (155.6 K). Kopin Cp is scheduled to announce its earnings today. The next earnings report is expected on the 1st of March 2022. Is technology space attracting new institutional investors, let's check if Kopin Cp is sending any bullish signals. We will evaluate why recent Kopin Cp price moves suggest a bounce in December. We currently estimate Kopin Cp as undervalued. The real value is approaching 6.83 per share.
IART
  over two months ago at Macroaxis 
By Vlad Skutelnik
Integra Lifesciences Return on Investment is comparatively stable at the moment as compared to the past year. Integra Lifesciences reported Return on Investment of 5.19 in 2020. Revenue to Assets is likely to gain to 0.53 in 2021, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop slightly above 239.7 M in 2021. Integra Lifesciences is scheduled to announce its earnings today. The next earnings report is expected on the 17th of February 2022. The stock is currently undergoing an active upward rally. Although many conservative investors are getting more into healthcare space, we should study Integra Lifesciences' newest fundamentals in more details. We will evaluate why we are still confident in anticipation of a recovery. Will private investors continue to hold, or should we expect a sell-off?
TTI
  over two months ago at Macroaxis 
By Raphi Shpitalnik
Tetra Technologies Earnings Before Interest Taxes and Depreciation Amortization EBITDA are most likely to decrease significantly in the upcoming years. The last year's value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA was reported at 26.24 Million. The current Average Equity is estimated to increase to about 326.7 M, while Net Income Per Employee is projected to decrease to (30.6 K). If you have been following Tetra you may be considering locking in. Let's check if stable basic indicators will continue to push the price to rise for Tetra Technologies' stockholders. The company current probability of distress is under 43 percent. Will stockholders continue to be optimistic, or should we expect a sell-off?
CRNT
  over two months ago at Macroaxis 
By Vlad Skutelnik
Ceragon Networks Enterprise Value over EBITDA is comparatively stable at the moment as compared to the past year. Ceragon Networks reported Enterprise Value over EBITDA of 49.41 in 2020. Free Cash Flow per Share is likely to gain to 0.15 in 2021, whereas Average Equity is likely to drop slightly above 137.7 M in 2021. In spite of comparatively stable basic indicators, Ceragon Networks is not utilizing all of its potentials. The current stock price uproar, may contribute to a short-horizon swings for the private investors. Will private investors continue to hold, or should we expect a sell-off?
NXTD
  over two months ago at Macroaxis 
By Ellen Johnson
In spite of rather weak basic indicators, Nxt Id exhibited solid returns over the last few months and may actually be approaching a breakup point. Will shareholders continue to hold, or should we expect a sell-off?
EQOS
  over two months ago at Macroaxis 
By Vlad Skutelnik
The stock is currently experiencing an active upward rally. Financial services space may be getting hot again, let's check if Diginex is sending any bullish signals to investors. I will address the reasons this entity was abused by retail investors resulted from the current market uncertainty. We currently estimate Diginex as undervalued. The real value is approaching 6.50 per share.
CHKP
  over two months ago at Macroaxis 
By Vlad Skutelnik
Check Point Tangible Asset Value is very stable at the moment as compared to the past year. Check Point reported last year Tangible Asset Value of 4.8 Billion. As of 28th of October 2021, Asset Turnover is likely to grow to 0.38, while Market Capitalization is likely to drop about 18.5 B. Check Point Software is scheduled to announce its earnings today. The next earnings report is expected on the 2nd of February 2022. As many risky investors are excited about technology space, it is only fair to recap Check Point Software based on its current volatility. We will evaluate why we are still confident in anticipation of a recovery. We currently estimate Check Point as undervalued. The real value is approaching 125.34 per share.
CBU
  over three months ago at Macroaxis 
By Vlad Skutelnik
Community Bank Enterprise Value over EBIT is comparatively stable at the moment as compared to the past year. Community Bank reported Enterprise Value over EBIT of 9.00 in 2020. Enterprise Value over EBITDA is likely to gain to 9.81 in 2021, whereas Average Assets are likely to drop slightly above 12 B in 2021. Community Bank System is scheduled to announce its earnings today. The next earnings report is expected on the 24th of January 2022. As some conservatives are trying to avoid financial services space, we'll review Community Bank System a little further and explain its current market possibilities. We will evaluate why we are still confident in anticipation of a recovery. Will private investors continue to hold, or should we expect a sell-off?
DORM
  over three months ago at Macroaxis 
By Ellen Johnson
Dorman Products Invested Capital is relatively stable at the moment as compared to the past year. The company's current value of Invested Capital is estimated at 478.3 Million. Invested Capital Average is expected to hike to about 475.1 M this year, although the value of Earnings before Tax will most likely fall to nearly 164.4 M. Even with relatively steady basic indicators, Dorman Products is not utilizing all of its potentials. The latest stock price chaos, may contribute to a medium-term swings for the stakeholders. We currently estimate Dorman Products as fairly valued. The real value is approaching 103.21 per share.